Investor mix
4 investors on record; lead investors include Drive Capital, Future Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |
Developer of AAV-delivered T-cell immunotherapies for the treatment of cancer
4 investors on record; lead investors include Drive Capital, Future Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |